Prosecution Insights
Last updated: May 29, 2026

Examiner: HAGOPIAN, CASEY SHEA

Tech Center 1600 • Art Units: 1615 1616 1617

This examiner grants 54% of resolved cases

Performance Statistics

54.4%
Allow Rate
-5.6% vs TC avg
610
Total Applications
+32.7%
Interview Lift
1210
Avg Prosecution Days
Based on 559 resolved cases, 2023–2026

Rejection Statute Breakdown

0.3%
§101 Eligibility
5.5%
§102 Novelty
59.4%
§103 Obviousness
10.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18463056 METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS Non-Final OA Zetagen Therapeutics, Inc.
18286541 BIOCHEMICAL ACTIVATION OF DYSFUNCTIONAL SKELETAL STEM CELLS FOR SKELETAL REGENERATION Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18046281 Thermoresponsive or Shear-Thinning Injectable Gel Compositions for Treatment of Arthritis Non-Final OA GLOBUS MEDICAL, INC.
16623167 INTEGRAL BIOMATERIAL FOR REGENERATION OF BONE TISSUE AND FABRICATION METHOD THEREFOR Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
19035278 DELIVERY DEVICE Final Rejection PTT HOLDING APS
18324941 NANOFIBER REINFORCEMENT OF ATTACHED HYDROGELS Non-Final OA Duke University
18252849 ELONGATED COMPOSITE FOR AN IMPLANT Non-Final OA 206 Ortho, Inc.
16768009 ADHESION LAYER BONDED TO AN ACTIVATED SURFACE Final Rejection THE TRUSTEES OF PRINCETON UNIVERSITY
18396941 IMPLANTABLE THERAPEUTIC DELIVERY SYSTEM AND METHODS THEREOF Final Rejection CORNELL UNIVERSITY
17795338 Herbicide combinations comprising glufosinate and trifludimoxazin Final Rejection COLORADO STATE UNIVERSITY RESEARCH FOUNDATION
17691262 Regenerative Tissue-Mimetic Multilayer Fused Microgel-Cell Construct Final Rejection University of South Carolina
18593164 RE-USABLE AND AFFIXABLE FACE COVERING OR MASK Non-Final OA Shawsheen Rubber Co., Inc.
18399206 HARD CAPSULE INCLUDING MULTIPLE LOCKING PARTS Final Rejection SUHEUNG CO., LTD.
18286181 AN ELASTOMERIC ARTICLE Non-Final OA MATANG MANUFACTURING SDN BHD
18375691 FUNCTIONALIZED NANOPARTICLES HAVING ENCAPSULATED GUEST CARGO AND METHODS FOR MAKING THE SAME Non-Final OA PENG, BERNEY
18278536 Insecticidal Composition Comprising of Diamide, Moulting Hormone Agonist and Pyrethroid Non-Final OA WILLOWOOD CHEMICALS LIMITED
18275263 Porous Osteoinductive Composites Non-Final OA Medskin Solutions Dr. Suwelack AG
18197813 PLA BEADS, DERMAL FILLER INCLUDING THE BEADS, APPARATUS INCLUDING THE FILLER AND USE OF THE APPARATUS Final Rejection Prollenium Medical Technologies, Inc.
17744248 Derivatized or Rapidly Polymerizing Collagen Compositions for Tissue Augmentation Containing Nonresorbable or Slowly Resorbable Polymers Final Rejection Shanghai Qisheng Biological Preparation Co., Ltd.
17928037 A METHOD OF COATING AN OCULAR PROSTHETIC DEVICE AND OTHER PROSTHETICS Non-Final OA UEA Enterprises Limited
17863251 METHODS AND DEVICES FOR NERVE REGENERATION Final Rejection Tulavi Therapeutics, Inc.
17684196 REINFORCED COLLAGEN DEVICE FOR SOFT TISSUE REPAIR Non-Final OA Harbor MedTech, Inc.
17635664 MESENCHYMAL STROMAL CELL BONE GRAFT MATERIAL Final Rejection Johann Wolfgang Goethe-Universität Frankfurt am Main
17534905 Ophthalmic Drug Compositions Non-Final OA Oxular Limited
16852870 MIXTURES OF SABADILLA ALKALOIDS AND PYRETHROIDS AND USES THEREOF Non-Final OA McLaughlin Gormley King Company
16841487 METHODS OF MANUFACTURING INJECTABLE MICROGEL SCAFFOLDS Final Rejection TEMPO THERAPEUTICS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month